A new breakthrough development in cancer treatment is chimeric antigen receptor (CAR)-T cell therapy. The authors focus on its efficacy & safety in prostate cancer, obstacles impeding its clinical use, and some strategies trying to overcome them.
[Biomarkers]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
169953
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
